In the BioHarmony Drug Report Database
Dornase alfa
Pulmozyme (dornase alfa) is an enzyme pharmaceutical. Dornase alfa was first approved as Pulmozyme on 1993-12-30. It is used to treat bronchitis and cystic fibrosis in the USA.
Trade Name
|
Pulmozyme |
|---|---|
Common Name
|
dornase alfa |
ChEMBL ID
|
CHEMBL1201431 |
Indication
|
bronchitis, cystic fibrosis |
Drug Class
|
Enzymes |
Image (chem structure or protein)
